Recombinant Human Ret Proto-oncogene, GST-tagged, Active

• Cat.No.: RET-417H
• Product Overview: Recombinant human RET (658-end) was expressed bybaculovirusinSf9 insect cellsusing an N-terminal GST tag. MW=74kDa.

Specification

• Cat. No.: RET-417H
• Description: RET gene codes for a transmembrane tyrosine kinase which is a subunit of a multimeric complex that acts as a receptor for four structurally related molecules: GDNF, neurturin, artemin and persephin. Germline mutations of RET cause a dominantly inherited dysgenesis of the enteric nervous system known as Hirschsprung"s disease. RET is constitutively activated by point mutations in hereditary medullary thyroid carcinomas (MTCs). Several single nucleotide polymorphisms of the RET gene have been described. Multiple endocrine neoplasia type 2A (MEN 2A) have been reported to be associated with two mutations of the protooncogene RET.
• Source: Sf9 insect cells using baculovirus.
• Sequence: 658-end.
• Applications: Kinase Assay, Western Blot.
• Storage And Stability: Store product at –70oC. For optimal storage, aliquot target into smaller quantities after centrifugation and store at recommended temperature. For most favorable performance, avoid repeated handling and multiple freeze/thaw cycles.

Gene Information

• Gene Name: RET ret proto-oncogene [ Homo sapiens ]
• Synonyms: RET1; ret proto-oncogene; RET transforming sequence; cadherin family member 12; hydroxyaryl-protein kinase; receptor tyrosine kinase; ret proto-oncogene (multiple endocrine neoplasia and medullary thyroid carcinoma 1, Hirschsprung disease); PTC; MTC1; HSCR1; MEN2A; MEN2B; RET51; CDHF12; RET-ELE1; EC 2.7.10.1
• Gene ID: 5979
• mRNA Refseq: NM_020630
• Protein Refseq: NP_065681
• MIM: 164761
• UniProt ID: P07949
• Chromosome Location: 10q11.2
• Pathway: Endocytosis; Pathways in cancer; Thyroid cancer
• Function: ATP binding; calcium ion binding; nucleotide binding; receptor activity; receptor activity; transferase activity; transmembrane receptor protein tyrosine kinase activity